Company: MDCXW
Filing Date: 2025-05-01
Form Type: DRS
Source: 0001062993-25-008292
Chunk: 201

Company: Medicus Pharma Ltd.
Filing Date: 2025-05-01
Form: DRS
Chunk 201
---
 of Common Shares Under the SEPA

We will have the right, but not the obligation, from time to time, at our sole and exclusive discretion, for the 36-month period after the date of the SEPA, to direct the Selling Shareholder to purchase up to a specified maximum amount of common shares as set forth in the SEPA by delivering written notice to the Selling Shareholder (each, an "Advance Notice") on any trading day (each, an "Advance Notice Date").

Conditions to Each Advance

The Selling Shareholder's obligation to accept Advance Notices that are timely delivered by us under the SEPA and to purchase our common shares in Advances under the SEPA are subject to the satisfaction, at the applicable Advance Notice Date, of the conditions precedent thereto set forth in the SEPA, all of which are entirely outside of the Selling Shareholder's control, which conditions include the following: (i) the accuracy in all material respects of our representations and warranties included in the SEPA; (ii) there being an effective registration statement pursuant to which the Selling Shareholder is permitted to utilize the prospectus thereunder to resell all of the Advance Shares pursuant to such Advance Notice; (iii) the sale and issuance of such Advance Shares being legally permitted by all laws and regulations to which we are subject; (iv) no Material Outside Event (as such term is defined in the SEPA) shall have occurred and be continuing; (v) the approval of our board of directors with respect to the transactions contemplated by the SEPA; (vi) us having performed, satisfied, and complied in all material respects with all covenants, agreements, and conditions required by the SEPA to be performed, satisfied, or complied with by us; (vii) no statute, rule, regulation, executive order, decree, ruling, or injunction having been enacted, entered, promulgated, or endorsed by any court or governmental authority of competent jurisdiction that prohibits or directly, materially, and adversely affects any of the transactions contemplated by the SEPA; (viii) trading in the common shares have not been suspended by the SEC, the Nasdaq Capital Market or FINRA (ix) no notice having been provided to us that the listing or quotation of the common shares shall be terminated; (x) no continued suspensions or restrictions by DTC of, nor continued notices that DTC is contemplating or imposing suspensions or restrictions on, accepting deposits of the common shares, electronic trading or book-entry services by DTC with respect to